Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page
- Check5 days agoChange DetectedRevision metadata in the history has been updated from v3.6.5 to v3.6.6, signaling a minor version bump in the site's revision tracking.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history now includes a new revision entry v3.6.5 and removes the previous revision v3.6.4, reflecting an update to the page's version tracking.SummaryDifference0.1%

- Check40 days agoChange DetectedThe record history shows a new software revision, v3.6.4, replacing the previous v3.6.3. This reflects a back-end or UI update to the page history display and does not alter study data or status.SummaryDifference0.1%

- Check62 days agoChange DetectedNew revision entry v3.6.3 was added to the history. The previous revision v3.6.2 was removed, updating the documented version trail for the study record.SummaryDifference0.1%

- Check69 days agoChange DetectedThe study record history now includes revision v3.6.2, replacing the prior revision v3.6.0. This reflects an administrative update to the page's versioning rather than a change to trial data or conduct.SummaryDifference0.1%

- Check83 days agoChange DetectedA new version v3.6.0 was added with an explicit note that the study is no longer looking for participants. The previous revision v3.5.5 was deleted from the history.SummaryDifference0.5%

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.